Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Roche Products Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (82)
Cancellation by sponsor (50)
Australian Public Assessment Report (AusPAR) (43)
Prescription medicine registration (33)
Prescription medicine decision summary (5)
Designation or determination (3)
Prescription medicine evaluation (3)

Date

2026 (8)
2025 (14)
2024 (15)
2023 (22)
2022 (9)
2021 (19)
2020 (16)
2019 (13)
2018 (11)
2017 (16)
2016 (6)
2015 (8)
2014 (5)
2013 (11)
2012 (3)
2011 (5)
2010 (4)
2009 (12)
2008 (2)
2006 (6)
2002 (1)
2000 (3)
1999 (1)
1997 (2)
1994 (1)
1993 (1)
1991 (5)

Search

Sponsor content

219 result(s) found, displaying 191 to 200

AusPAR: Tocilizumab

15 December 2011

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Tocilizumab
AusPAR: Rituximab

15 December 2011

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Rituximab
AusPAR: Oseltamivir phosphate

10 August 2011

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Oseltamivir phosphate
AusPAR: Tocilizumab

17 February 2011

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Tocilizumab
AusPAR: Trastuzumab

15 February 2011

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Trastuzumab
NEORECORMON epoetin beta (rch) 5000 IU/0.3 mL injection syringe (104265)

9 January 2006

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NEORECORMON epoetin beta (rch) 5000 IU/0.3 mL injection syringe.
NEORECORMON epoetin beta (rch) 2000 IU/0.3 mL injection syringe (104262)

9 January 2006

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NEORECORMON epoetin beta (rch) 2000 IU/0.3 mL injection syringe.
NEORECORMON epoetin beta (rch) 10 000 IU/0.6 mL injection syringe (104267)

9 January 2006

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NEORECORMON epoetin beta (rch) 10 000 IU/0.6 mL injection syringe.
NEORECORMON epoetin beta (rch) 6000 IU/0.3 mL injection syringe (104266)

9 January 2006

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NEORECORMON epoetin beta (rch) 6000 IU/0.3 mL injection syringe.
NEORECORMON epoetin beta (rch) 4000 IU/0.3 mL injection syringe (104264)

9 January 2006

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NEORECORMON epoetin beta (rch) 4000 IU/0.3 mL injection syringe.

Pages

First page
Previous page
…
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Current page 20
Page 21
Page 22
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.